جهت دسترسی به کاربرگه ی زیر، از این لینک استفاده کنید. http://78.39.227.9/handle/Hannan/57173
Title: Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial.
Authors: Vermeire, Séverine;O'Byrne, Sharon;Keir, Mary;Williams, Marna;Lu, Timothy T;Mansfield, John C;Lamb, Christopher a;Feagan, Brian G;Panes, Julian;Salas, Azucena;Baumgart, Daniel C;Schreiber, Stefan;Dotan, Iris;Sandborn, William J;Tew, Gaik W;Luca, Diana;Tang, Meina T;Diehl, Lauri;Eastham-Anderson, Jeffrey;De Hertogh, Gert;Perrier, Clementine;Egen, Jackson G;Kirby, John a;van Assche, Gert;Rutgeerts, Paul
Issue Date: 2014
Abstract: BACKGROUND: Etrolizumab is a humanised monoclonal antibody that selectively binds the β7 subunit of the heterodimeric integrins α4β7 and αEβ7. We aimed to assess etrolizumab in patients with moderately-to-severely active ulcerative colitis.\n\nMETHODS: In
URI: http://www.ncbi.nlm.nih.gov/pubmed/24814090
http://ebook.muk.ac.ir/handle/Hannan/57173
Format: VOLUME : 6736
ISSUE : 14
START PAGE : 1
END PAGES : 10
Appears in Collections:2014

Files in This Item:
File Description SizeFormat 
medicine article zl (96).pdf116.96 kBAdobe PDFThumbnail
Preview File    Request a copy


تمامی کاربرگه ها در کتابخانه ی دیجیتال حنان به صورت کامل محافظت می شوند.